Relay Therapeutics, Inc.

RLAY ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $844.0M

Liabilities Breakdown FY2023

Total Liabilities: $92.0M